Viktoriya Tigipko

Berry Street is on a mission to transform how Americans eat through nutrition therapy. Berry Street’s platform connects individuals needing evidence-based nutrition care with an expansive network of Registered Dietitians and AI-powered tools. From weight management, diabetes, and heart health to kidney disease, maternal health, and 25+ other conditions, Berry Street’s clinical team delivers personalized nutrition interventions tailored to each patients unique physiological and psychological needs, improving outcomes and reducing total cost of care. Berry Street works with some of the largest health plans, as well as leading health systems and innovative care management companies to serve diverse populations across all 50 states. Visit berrystreet.co to learn more.

Proteinea is a pioneering TechBio company transforming drug discovery and development by integrating advanced biotechnology with artificial intelligence. Our mission is to accelerate the development of life-saving therapies, pushing the boundaries of science and technology to improve patient outcomes.

Fintech Farm helps traditional banks to create and run digital banks (aka neobanks). We provide an amazing mobile app as well as an entire end-to-end tech stack. We develop credit engines and AI-powered credit models. We build data-driven customer acquisition and retention processes. We know how to create great customer service so that customers not just use our bank, but really love it.

Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives. Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. We aim to change that. Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, we have developed a platform to produce female reproductive cell lines. We use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Our team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Our first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno.

Destinus builds Europe’s capacity to strike, defend, and replenish at scale. We design and manufacture cruise missiles, guided rockets, ballistic systems, and interceptors. Behind them sits a vertically integrated base of propulsion, warheads, autonomy, and critical manufacturing. Destinus turns European engineering into sovereign military capability. Produced across Europe. Owned in Europe. Made for Europe.

Korean effectiveness meets sustainable solutions: our mindfully produced skincare products are made with love in Korea. Yepoda’s mission is to bring you the best natural and active ingredients without ever compromising on quality or sustainability. We are a young skincare start-up launched in spring 2020, and proudly recognised as one of LinkedIns Top Startups 2025 in Germany. Would you like to join us? Check our website!

GROPYUS advances the development of sustainable buildings. We transform the construction industry through technology. By looking at homes as products we are able to create truly sustainable and affordable buildings. Sustainability permeates every step of the building process: design, production, construction, and asset management. We create a new standard of sustainable living for people and conserve the resources of our planet. Let’s build sustainable and affordable homes together! Legal Notice: https://www.gropyus.com/en/legal-notice Privacy Policy: https://www.gropyus.com/en/data-privacy

Cast AI is the automation platform for cloud-native and AI workloads that keeps applications reliable and performant, with cost savings as a natural outcome.

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of todays most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.

At Liki24, we’re on a mission to make health, wellness, and beauty products more affordable and accessible for everyone. We started in Ukraine in 2017 and have grown across Europe, now serving 10 countries, including Romania, Italy, Germany, Austria, France, the Netherlands, Belgium, UK and Spain, with our headquarters in Bucharest, Romania. We connect customers with a wide range of trusted health & wellness providers - from online pharmacies and drogeries to beauty and care brands, supplement sellers, and medical device suppliers. With 100K+ products from over 12K+ sellers and 27K+ pickup points, we help 2M+ customers find what they need, when and where they need it. But Liki24 is more than just a marketplace. We’re building a full ecosystem that unites pharmacies, logistics providers, insurance companies, clinics, doctors, telemedicine platforms, and healthcare brands — all to make health shopping faster, smarter, and borderless. We believe in health without borders — anyone, anywhere in Europe, should have easy access to trusted healthcare products at fair prices — in just a few clicks. Join us in shaping the future of health commerce!

Show Your Teeth with Impress – Europe’s #1 Orthodontic Clinics Impress operates over 110 clinics across 10 countries in Europe and the United States, transforming orthodontic care with cutting-edge clear aligner treatments. Our clear aligners are the preferred choice for both orthodontists and patients, offering a seamless way to achieve aligned, healthy teeth with ease, discretion, and comfort. We believe in empowering individuals to show their teeth and face the world with confidence and self-assurance. With over 15 years of expertise, our skilled orthodontists partner closely with the Impress medical team to develop personalized treatment plans that deliver visible results in as little as 6 months. In 2024, we strengthened our leadership in the orthodontics industry by acquiring DR SMILE, furthering our mission to make high-quality orthodontic care accessible to an even wider audience. With ambitious plans to expand through new clinic openings and market entries, we’re committed to reshaping the future of oral health care. Join over 200,000 satisfied patients worldwide who have transformed their smiles with Impress. Ready to take the first step? Show your teeth with Impress today!

Tandem Bank - Helping you get more from your money Experts in savings, lending and green consumer finance, we pioneer smart products and new technology to remove financial barriers and make it easier to manage your money. From big decisions like green mortgages and green home improvements loans, to everyday choices that help you make the most of your money, we support customers to make choices that are better for them and for the planet. 🤝 The Sunday Times Best Places To Work 2024 and 2025 🤝 The Sunday Times 100 Tech 2025 - top 100 fastest growing tech companies in Britain. 🤝 Certification from Great Place To Work UK 2025

Imagine if your bank took 7% of every transfer you made. Sounds crazy, doesnt it? And yet its reality for hard-working people who send money abroad. Azimo was founded in 2012 with a strong social purpose: to make it cheaper and easier for people to support their loved ones back home.

Launched in 2015, by 2020 Prima had become the leader in Italy’s online motor insurance market, redesigning and digitalising the entire insurance value chain and building its proprietary technology platforms from the ground up, based on a cutting-edge stack and advanced data analytics capabilities. Prima was backed by some of the world’s most prestigious financial institutions. Goldman Sachs and The Blackstone Group invested in 2018, in what was at the time the largest venture capital round ever raised in Italy. The Carlyle Group joined the shareholder base in 2022. All of these investors exited in November 2025, when Prima became part of the AXA Group. In 2021, Prima launched its Home and Family product and began its journey to become a single point of reference for customers looking to purchase insurance products. In 2022, Prima started its international expansion. Today, we have a team of over 100 professionals in London and more than 90 in Madrid, supporting growth in the UK and Spanish markets. 💻 https://www.prima.it 💻 https://www.helloprima.co.uk 💻 https://www.helloprima.es/

SumUp is a leading global fintech company committed to levelling the playing field for small businesses. Founded in 2012, we’re the trusted partner of over 4 million merchants in 37 markets, providing simple and affordable tools that help them manage payments, finance, and customer relationships. Our vision is a world where everyone can build a thriving business. Guided by this, we champion small business ownership by creating accessible solutions that empower entrepreneurs to grow and succeed. Our diverse team of over 3,000 SumUppers — representing more than 90 nationalities across 20 offices worldwide — is at the heart of our success. Beyond business, we donate 1% of the net revenue generated by Solo devices to environmental causes and support educational and entrepreneurial initiatives around the world. Recognised as a Top Global Employer for inclusion by the Stonewall Workplace Equality Index in 2022 and 2023, and awarded Fintech Diversity Initiative of the Year at the Irish National Fintech Awards in 2025, SumUp continues to build an inclusive, supportive, and purpose-driven workplace where everyone belongs.

Tarjama is the MENA regions leading language technology company, specializing in Arabic Language AI and translation solutions. With over 16 years of innovation, we combine cutting-edge AI with human expertise to deliver high-quality translation and localization services to a global audience. As pioneers in Arabic Language AI, we focus on the fine-tuning of large language models (LLMs) and the training of AI models to better serve the unique nuances of the Arabic language. This expertise allows us to create tailor-made solutions for clients across industries, ensuring precision and cultural relevance in every project. Our services span AI-powered translation, transcription, content localization, and multilingual content creation. Our suite of innovative products includes: * AMT (Arabic Machine Translation) – An instant highly-accurate machine translation engine designed to handle the complexities of Arabic language processing. * CleverSo – An AI-powered translation management system designed to streamline workflows and enhance productivity for businesses. * T-Portal – A comprehensive platform offering a wide range of content services, from localization and translation to dubbing, subtitling, and more. * FastScribe – A fast, reliable transcription and translation tool for more than 55+ languages. In addition to these products, we offer a wide range of AI-driven services to help businesses leverage the full potential of their data. Our AI services include: - Data Annotation & Labeling – High-quality, scalable annotation services for training AI models. - Prompt Engineering – Optimizing AI models through advanced prompt design and fine-tuning. - Arabic AI Agent: our finetuned legal LLM agent Trusted by over 700 clients worldwide, including leading enterprises and governmental organizations, Tarjama is at the forefront of advancing language AI, enabling businesses to seamlessly operate in multiple languages while maintaining a strong cultural presence.

Berry Street is on a mission to transform how Americans eat through nutrition therapy. Berry Street’s platform connects individuals needing evidence-based nutrition care with an expansive network of Registered Dietitians and AI-powered tools. From weight management, diabetes, and heart health to kidney disease, maternal health, and 25+ other conditions, Berry Street’s clinical team delivers personalized nutrition interventions tailored to each patients unique physiological and psychological needs, improving outcomes and reducing total cost of care. Berry Street works with some of the largest health plans, as well as leading health systems and innovative care management companies to serve diverse populations across all 50 states. Visit berrystreet.co to learn more.

Proteinea is a pioneering TechBio company transforming drug discovery and development by integrating advanced biotechnology with artificial intelligence. Our mission is to accelerate the development of life-saving therapies, pushing the boundaries of science and technology to improve patient outcomes.

Fintech Farm helps traditional banks to create and run digital banks (aka neobanks). We provide an amazing mobile app as well as an entire end-to-end tech stack. We develop credit engines and AI-powered credit models. We build data-driven customer acquisition and retention processes. We know how to create great customer service so that customers not just use our bank, but really love it.

Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives. Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. We aim to change that. Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, we have developed a platform to produce female reproductive cell lines. We use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Our team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Our first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno.